Ondrej Bilek

Brno, JM, CZ 
Brno, JM, CZ 

Overview

Ondrej Bilek practices practicing medicine in Brno, Czech Republic.

His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Ewing Sarcoma, Mediastinal Tumor, and Penectomy.

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Brno, JM 61300, Czech Republic
Other Locations
Zlin, 76001, Czech Republic
Ostrava, MO, Czech Republic

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: March 04, 2026
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3

35 Total Publications

Altered cytokinin signaling drives plant drought resilience through lipid remodeling, nutrient homeostasis, cell wall reinforcement, and modulation of biotic stress-associated pathways.
Altered cytokinin signaling drives plant drought resilience through lipid remodeling, nutrient homeostasis, cell wall reinforcement, and modulation of biotic stress-associated pathways.
Journal: Plant physiology and biochemistry : PPB
Published: March 17, 2026

Frequently Asked Questions about Ondrej Bilek

Is Ondrej Bilek a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Ondrej Bilek is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ondrej Bilek participate in research or clinical trials?

Yes. Ondrej Bilek has published 35 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Ondrej Bilek's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bilek's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile